Becton, Dickinson and Company Stock
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 203.39 USD | -1.80% |
|
+0.93% | +4.80% |
| 01-16 | Becton Dickinson & Co Insider Sold Shares Worth $334,005, According to a Recent SEC Filing | MT |
| 01-15 | Becton, Dickinson Says FDA Clears Breast Biopsy and Tissue Removal System | MT |
| Capitalization | 59.01B 50.29B 46.6B 43.82B 81.57B 5,370B 87.5B 538B 212B 2,554B 221B 217B 9,319B | P/E ratio 2026 * |
30.9x | P/E ratio 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise value | 74.72B 63.68B 59B 55.49B 103B 6,800B 111B 681B 269B 3,233B 280B 274B 11,800B | EV / Sales 2026 * |
3.32x | EV / Sales 2027 * | 3.1x |
| Free-Float |
77.04% | Yield 2026 * |
1.98% | Yield 2027 * | 2.04% |
Last Transcript: Becton, Dickinson and Company
| 1 day | -1.80% | ||
| 1 week | +0.93% | ||
| Current month | +4.80% | ||
| 1 month | +3.38% | ||
| 3 months | +6.49% | ||
| 6 months | +16.00% | ||
| Current year | +4.80% |
| 1 week | 200.81 |  | 209.27 |
| 1 month | 192.48 | | 209.27 |
| Current year | 192.48 | | 209.27 |
| 1 year | 162.29 | | 251.98 |
| 3 years | 162.29 | | 287.32 |
| 5 years | 162.29 | | 287.32 |
| 10 years | 129.5 | | 287.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 53 | 2020-01-27 |
| Chief Tech/Sci/R&D Officer | 50 | 2018-12-31 | |
Claudia Curtis
CMP | Compliance Officer | - | 2023-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 75 | 2002-09-23 |
| Director/Board Member | 71 | 2006-11-19 | |
| Director/Board Member | 71 | 2010-07-25 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.29% | 15.4% | 253 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.80% | +0.93% | -15.38% | -19.87% | 59.01B | |
| -0.51% | -2.54% | +3.72% | +7.37% | 212B | |
| +1.90% | +2.26% | +11.56% | +21.86% | 124B | |
| -1.18% | +1.38% | +43.09% | +116.18% | 68.84B | |
| -0.54% | +0.28% | +22.12% | +85.36% | 53.93B | |
| +0.07% | +3.03% | - | - | 36.72B | |
| +1.71% | +0.68% | -18.06% | -34.42% | 27.12B | |
| -3.97% | -0.72% | +18.85% | +25.78% | 26.37B | |
| +0.05% | -4.00% | +4.77% | -33.44% | 23.37B | |
| -0.12% | -4.96% | -26.12% | +15.81% | 20.12B | |
| Average | -0.40% | +1.24% | +4.95% | +20.51% | 65.12B | |
| Weighted average by Cap. | -0.31% | +0.17% | +8.25% | +24.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 22.52B 19.19B 17.78B 16.73B 31.13B 2,050B 33.4B 205B 81.1B 975B 84.45B 82.72B 3,557B | 23.31B 19.87B 18.41B 17.31B 32.22B 2,121B 34.56B 212B 83.94B 1,009B 87.4B 85.61B 3,681B |
| Net income | 2.02B 1.72B 1.6B 1.5B 2.79B 184B 3B 18.42B 7.28B 87.47B 7.58B 7.42B 319B | 2.38B 2.03B 1.88B 1.77B 3.29B 217B 3.53B 21.69B 8.57B 103B 8.92B 8.74B 376B |
| Net Debt | 15.71B 13.39B 12.41B 11.67B 21.72B 1,430B 23.29B 143B 56.57B 680B 58.91B 57.7B 2,481B | 13.36B 11.38B 10.55B 9.92B 18.47B 1,216B 19.81B 122B 48.1B 578B 50.09B 49.06B 2,109B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-20 | 203.39 $ | -1.80% | 1,566,804 |
| 26-01-16 | 207.11 $ | -0.60% | 1,590,433 |
| 26-01-15 | 208.35 $ | +0.45% | 2,170,974 |
| 26-01-14 | 207.42 $ | +2.93% | 1,442,810 |
| 26-01-13 | 201.52 $ | -0.60% | 1,158,393 |
Delayed Quote Nyse, January 20, 2026 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BDX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition